TETRALOGIC PHARMACEUTICALS
TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The company's Smac Mimetics neutralize critical blocks in the apoptosis pathway to selectively destroy cancer cells. Its Necrostatin drugs block critical steps in the process leading to necrosis, enabling cell survival in a wide range of diseases and injuries where necrosis is a critical component of pathology.
TETRALOGIC PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.tetralogicpharma.com
Total Employee:
11+
Status:
Active
Contact:
6108899900
Email Addresses:
[email protected]
Total Funding:
164 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Cloudflare Hosting Cloudflare DNS
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-04-08 | Shape Pharmaceuticals | Shape Pharmaceuticals acquired by TetraLogic Pharmaceuticals | 13 M USD |
Investors List
Nextech Invest
Nextech Invest investment in Series C - TetraLogic Pharmaceuticals
Quaker BioVentures
Quaker BioVentures investment in Series C - TetraLogic Pharmaceuticals
The Vertical Group
The Vertical Group investment in Series C - TetraLogic Pharmaceuticals
Amgen Ventures
Amgen Ventures investment in Series C - TetraLogic Pharmaceuticals
HealthCare Ventures
HealthCare Ventures investment in Series C - TetraLogic Pharmaceuticals
Pfizer Venture Investments
Pfizer Venture Investments investment in Series C - TetraLogic Pharmaceuticals
Clarus Ventures
Clarus Ventures investment in Series C - TetraLogic Pharmaceuticals
Hatteras Venture Partners
Hatteras Venture Partners investment in Series C - TetraLogic Pharmaceuticals
Novitas Capital
Novitas Capital investment in Series C - TetraLogic Pharmaceuticals
Latterell Venture Partners
Latterell Venture Partners investment in Series C - TetraLogic Pharmaceuticals
Official Site Inspections
http://www.tetralogicpharma.com
- Host name: 104.21.17.212
- IP address: 104.21.17.212
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
